Sofia Warner | Senior Director, Investor Relations |
João Siffert | Chief Executive Officer, Head of Research & Development and Chief Medical Officer |
Timothy Miller | President and Chief Scientific Officer |
Christine Berni-Silverstein | Chief Financial Officer |
David Steinberg | Jefferies & Company, Inc. |
Liav Abraham | Citigroup |
Edward Marks | H.C. Wainwright & Co., LLC, |
Fang-Ke Huang | SunTrust Robinson Humphrey, Inc. |
Vikram Kaushik | RBC Capital Markets |
Elemer Piros | Cantor Fitzgerald & Co. |
Good morning, ladies and gentlemen, and welcome to the Abeona Therapeutics Inc., First Quarter 2019 Earnings and Business Update Conference Call. Today's call is being recorded. And at this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation.
For opening remarks and introductions, I'll turn the call over to Sofia Warner, Senior Director, Investor Relations.